Search research articles
Contact Us
Filters
Showing results (1-10 of 88) with videos related to
Page
of 9
Sort By:
The AAPS Journal
|
October 3, 2007
Polymer-drug conjugates as modulators of cellular apoptosis
María J Vicent
Biomacromolecules
|
October 9, 2014
Reduction sensitive Poly(l-glutamic acid) (PGA)-protein conjugates designed for polymer masked-unmasked protein therapy
Marina Talelli, María J Vicent
Advanced Drug Delivery Reviews
|
December 17, 2009
Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities
Ruth Duncan, María J Vicent
Advanced Drug Delivery Reviews
|
August 25, 2009
Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines
Francesca Greco, María J Vicent
Advanced Drug Delivery Reviews
|
September 18, 2012
Polymer therapeutics-prospects for 21st century: the end of the beginning
Ruth Duncan, María J Vicent
Trends in Biotechnology
|
November 26, 2005
Polymer conjugates: nanosized medicines for treating cancer
María J Vicent, Ruth Duncan
Journal of Medicinal Chemistry
|
June 23, 2006
Poly-L-glutamic acid (PGA) aided inhibitors of apoptotic protease activating factor 1 (Apaf-1): an antiapoptotic polymeric nanomedicine
María J Vicent, Enrique Pérez-Payá
Current Opinion in Biotechnology
|
July 5, 2011
Polymer--drug conjugates as nano-sized medicines
Fabiana Canal, Joaquin Sanchis, María J Vicent
Macromolecular Bioscience
|
December 7, 2017
pH-Responsive Polyacetal-Protein Conjugates Designed for Polymer Masked-Unmasked Protein Therapy (PUMPT)
Gabriela Rodríguez Escalona, Joaquin Sanchis, María J Vicent
Current Topics in Medicinal Chemistry
|
February 3, 2007
Discovery of inhibitors of protein-protein interactions from combinatorial libraries
María J Vicent, Enrique Pérez-Payá, Mar Orzáez
Page
of 9
Search research articles
Search
Showing results (1-10 of 88) with videos related to
Sort By:
Page
of 9
The AAPS Journal
|
October 3, 2007
Polymer-drug conjugates as modulators of cellular apoptosis
María J Vicent
Biomacromolecules
|
October 9, 2014
Reduction sensitive Poly(l-glutamic acid) (PGA)-protein conjugates designed for polymer masked-unmasked protein therapy
Marina Talelli, María J Vicent
Advanced Drug Delivery Reviews
|
December 17, 2009
Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities
Ruth Duncan, María J Vicent
Advanced Drug Delivery Reviews
|
August 25, 2009
Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines
Francesca Greco, María J Vicent
Advanced Drug Delivery Reviews
|
September 18, 2012
Polymer therapeutics-prospects for 21st century: the end of the beginning
Ruth Duncan, María J Vicent
Trends in Biotechnology
|
November 26, 2005
Polymer conjugates: nanosized medicines for treating cancer
María J Vicent, Ruth Duncan
Journal of Medicinal Chemistry
|
June 23, 2006
Poly-L-glutamic acid (PGA) aided inhibitors of apoptotic protease activating factor 1 (Apaf-1): an antiapoptotic polymeric nanomedicine
María J Vicent, Enrique Pérez-Payá
Current Opinion in Biotechnology
|
July 5, 2011
Polymer--drug conjugates as nano-sized medicines
Fabiana Canal, Joaquin Sanchis, María J Vicent
Macromolecular Bioscience
|
December 7, 2017
pH-Responsive Polyacetal-Protein Conjugates Designed for Polymer Masked-Unmasked Protein Therapy (PUMPT)
Gabriela Rodríguez Escalona, Joaquin Sanchis, María J Vicent
Current Topics in Medicinal Chemistry
|
February 3, 2007
Discovery of inhibitors of protein-protein interactions from combinatorial libraries
María J Vicent, Enrique Pérez-Payá, Mar Orzáez
Page
of 9